NANOVIRICIDES, INC.NNVCEarnings & Financial Report
NYSE
NNVC Q2 2026 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-2.2M
Net Profit
$-2.2M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.11
NANOVIRICIDES, INC. Q2 2026 Financial Summary
NANOVIRICIDES, INC. reported revenue of $0 for Q2 2026, with a net profit of $-2.2M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-2.2M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q2 2026 |
NANOVIRICIDES, INC. Annual Revenue by Year
NANOVIRICIDES, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $0).
| Year | Annual Revenue |
|---|---|
| 2025 | $0 |
| 2024 | $0 |
| 2023 | $0 |
Income Statement
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $11.5M | $12.8M | $11.7M | $11.6M | $10.0M | $8.8M | $8.4M | $12.3M |
| Liabilities | $813337 | $1.4M | $1.6M | $1.2M | N/A | $1.3M | $1.2M | $1.2M |
| Equity | $10.7M | $11.5M | $10.1M | $10.4M | $8.8M | $7.5M | $7.2M | $11.1M |
Cash Flow
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-1.9M | $-1.5M | $-2.6M | $-2.2M | $-2.0M | $-1.7M | $-1.6M | $-2.0M |